Katsuya Fujita

Role of endothelin‐1 and the ET_A receptor in the maintenance of deoxycorticosterone acetate‐salt‐induced hypertension

Katsuya Fujita, Yasuo Matsumura, Satomi Kita et al. · British Journal of Pharmacology · 1995 · 95 citations · Full text

Medicine, Pharmacology, Physiology +17

SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity

Tetsuro Nariai, Katsuya Fujita, Masaya Mori et al. · Journal of Pharmacological Sciences · 2011 · 32 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

SM-368229, a Novel Promising Mineralocorticoid Receptor Antagonist, Shows Antihypertensive Efficacy With Minimal Effect on Serum Potassium Level in Rats

Tetsuro Nariai, Katsuya Fujita, Masaya Mori et al. · Journal of Cardiovascular Pharmacology · 2012 · 28 citations

Medicine, Cardiology, Pharmacology +16

Effects of the Endothelin ETA-Receptor Antagonist FR139317 on Development of Hypertension and Cardiovascular Hypertrophy in Deoxycorticosterone Acetate-Salt Hypertensive Rats

Katsuya Fujita, Yasuo Matsumura, Yohko Miyazaki et al. · The Japanese Journal of Pharmacology · 1996 · 25 citations · Full text

Medicine, Pharmacology, Physiology +14

Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase

Katsuya Fujita, Yasuo Matsumura, Yohko Miyazaki et al. · European Journal of Pharmacology · 1995 · 24 citations

Medicine, Pharmacology, Physiology +12